|
1. Heart Disease Facts and Statistics.Centers for Disease Control and Prevention. Accessed at www.cdc.gov/heartDisease/statistics.htm. August 22 2009
2. Heart Disease and Stroke Statistics. American Heart Association 2009, Dallas. Statistics Committee and Stroke Statistics Subcommittee. Circulation, Dec 15, 2008.
3. Azzazy HM, Christenson RH. Cardiac markers of acute coronary syndromes: Is there a case for point-of-care testing? Clin Biochem 2002; 35:13-27.
4. McDonnell B, Hearty S, Leonard P, O'Kennedy R. Cardiac biomarkers and the case for point-of-care testing. Clin Biochem 2009; 42:549-61. Epub 2009 Feb 7.
5. Carreiro-Lewandowski E: Update on cardiac biomarkers, Lab Med 2006; 37:598-605
6. Hand M, Brown C, Horan M, Simons-Morton D. The National Heart Attack Alert Program: progress at 5 Years in Educating Providers, Patients, and the Public and Future Directions. J Thromb Thrombolysis 1998; 6:9-17.
7. Hawkins RC. Laboratory turnaround time. Clin Biochem Rev 2007;28:179-194.8. Novis DA, Jones BA, Dale JC, Walsh MK. Biochemical markers of myocardial injury test turnaround time: A College of American Pathologists Q-Probes study of 7020 troponin and 4368 creatine kinase-MB determinations in 159 institutions. Arch Pathol Lab Med 2004;128:158-64.
9. Gibler WB, Blomkalns AL, editors. Point-of-Care Testing for Cardiac Biomarkers in the ED: A Blueprint for Implementation. From Advancing the Standard of Care: Cardiovascular and Neurovascular Emergencies, July 2006. EMCREG-International. www.emcreg.org/publications/monographs/acep/2006/acep2006_mono.html
10. Friess U, Stark M. Cardiac markers: a clear cause for point-of-care testing. Anal Bioanal Chem 2009; 393:1453-62. Epub 2009 Jan 16.
11. Johnson K, McMillin G. (2009). Enzymes. (p.281-308). Clinical Chemistry: techniques, principles & correlations, Philadelphia: Lippincott, Williams & Wilkins.
12. Karras DJ, Kane DL. Serum markers in the emergency department diagnosis of acute myocardial infarction. Emerg Med Clin North Am 2001; 19:321-37.
13. Adams JE III, Sicard GA, Allen BT, Bridwell KH, Lenke LG, Dávila-Román VG, Bodor GS, Ladenson JH, Jaffe AS. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 1994; 330:670-4
14. Omland T, Persson A, Ng L, O'Brien R, Karlsson T, Herlitz J, Hartford M, Caidahl K. N-terminal pro-B-type natriuretic peptide and long-term mortality in acute coronary syndromes. Circulation 2002; 106:2913-8.
15. Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002; 48:691-8.
16. Nichols JH: Point of care testing. Clin Lab Med 2007; 4:893-908.
17. Kurihara T, Yanagida A, Yokoi H, Koyata A, Matsuya T, Ogawa J, Okamura Y, Miyamoto D. Evaluation of cardiac assays on a benchtop chemiluminescent enzyme immunoassay analyzer, PATHFAST. Anal Biochem 2008; 375:144-6. Epub 2007 Dec 31.
18. Singer AJ, Ardise J, Gulla J, Cangro J. Point-of-care testing reduces length of stay in emergency department chest pain patients. Ann Emerg Med 2005; 45:587-91.
19. Apple FS, Chung AY, Kogut ME, Bubany S, Murakami MM. Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit. Clin Chim Acta 2006; 370:191-5. Epub 2006 Mar 6.
|